Viewing Study NCT06462469


Ignite Creation Date: 2025-12-24 @ 11:05 PM
Ignite Modification Date: 2025-12-25 @ 8:36 PM
Study NCT ID: NCT06462469
Status: RECRUITING
Last Update Posted: 2025-11-25
First Post: 2024-06-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module